{"frames":[{"target":{"name":"Craft","spans":[{"start":0,"end":1,"text":"Science"}]},"annotationSets":[{"rank":0,"score":11.691366466170551,"frameElements":[]}]},{"target":{"name":"Medical_specialties","spans":[{"start":2,"end":3,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":4.571156479647906,"frameElements":[{"name":"Specialty","spans":[{"start":0,"end":3,"text":"Science translational medicine"}]}]}]}],"tokens":["Science","translational","medicine","."]}
{"frames":[{"target":{"name":"Building_subparts","spans":[{"start":9,"end":10,"text":"cells"}]},"annotationSets":[{"rank":0,"score":17.685470341865443,"frameElements":[{"name":"Building_part","spans":[{"start":9,"end":10,"text":"cells"}]}]}]}],"tokens":["A","DLL3-targeted","antibody-drug","conjugate","eradicates","high-grade","pulmonary","neuroendocrine","tumor-initiating","cells","in","vivo","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":4,"end":5,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":32.972942829277486,"frameElements":[{"name":"Ailment","spans":[{"start":4,"end":5,"text":"tumors"}]}]}]},{"target":{"name":"Dimension","spans":[{"start":6,"end":7,"text":"small"}]},"annotationSets":[{"rank":0,"score":22.65831764677904,"frameElements":[{"name":"Object","spans":[{"start":7,"end":8,"text":"cell"}]},{"name":"Dimension","spans":[{"start":6,"end":7,"text":"small"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":7,"end":8,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.813941750558723,"frameElements":[{"name":"Building_part","spans":[{"start":7,"end":8,"text":"cell"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":9,"end":10,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":33.85388276884195,"frameElements":[]}]},{"target":{"name":"Dimension","spans":[{"start":14,"end":15,"text":"large"}]},"annotationSets":[{"rank":0,"score":21.932036131941974,"frameElements":[{"name":"Object","spans":[{"start":15,"end":16,"text":"cell"}]},{"name":"Dimension","spans":[{"start":14,"end":15,"text":"large"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":15,"end":16,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.770644039681095,"frameElements":[{"name":"Building_part","spans":[{"start":15,"end":16,"text":"cell"}]}]}]},{"target":{"name":"Existence","spans":[{"start":22,"end":23,"text":"remain"}]},"annotationSets":[{"rank":0,"score":37.74867165667961,"frameElements":[{"name":"Entity","spans":[{"start":23,"end":28,"text":"among the most deadly malignancies"}]}]}]},{"target":{"name":"Killing","spans":[{"start":26,"end":27,"text":"deadly"}]},"annotationSets":[{"rank":0,"score":77.58020346615073,"frameElements":[{"name":"Degree","spans":[{"start":25,"end":26,"text":"most"}]}]}]}],"tokens":["The","high-grade","pulmonary","neuroendocrine","tumors",",","small","cell","lung","cancer","-LRB-","SCLC","-RRB-","and","large","cell","neuroendocrine","carcinoma","-LRB-","LCNEC","-RRB-",",","remain","among","the","most","deadly","malignancies","."]}
{"frames":[{"target":{"name":"Cure","spans":[{"start":0,"end":1,"text":"Therapies"}]},"annotationSets":[{"rank":0,"score":51.61424229276315,"frameElements":[]}]},{"target":{"name":"Purpose","spans":[{"start":3,"end":4,"text":"target"}]},"annotationSets":[{"rank":0,"score":29.29158572056502,"frameElements":[{"name":"Agent","spans":[{"start":1,"end":2,"text":"that"}]}]}]},{"target":{"name":"Killing","spans":[{"start":5,"end":6,"text":"kill"}]},"annotationSets":[{"rank":0,"score":77.16626116624464,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":7,"end":8,"text":"cells"}]},"annotationSets":[{"rank":0,"score":18.78554611129867,"frameElements":[{"name":"Building_part","spans":[{"start":7,"end":8,"text":"cells"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":13,"end":14,"text":"cancers"}]},"annotationSets":[{"rank":0,"score":42.945015185229785,"frameElements":[]}]},{"target":{"name":"Being_obligated","spans":[{"start":14,"end":15,"text":"should"}]},"annotationSets":[{"rank":0,"score":17.765941241429662,"frameElements":[{"name":"Responsible_party","spans":[{"start":11,"end":14,"text":"in these cancers"}]}]}]},{"target":{"name":"Categorization","spans":[{"start":15,"end":16,"text":"translate"}]},"annotationSets":[{"rank":0,"score":32.970107732688604,"frameElements":[{"name":"Cognizer","spans":[{"start":6,"end":8,"text":"tumor-initiating cells"}]},{"name":"Item","spans":[{"start":12,"end":14,"text":"these cancers"}]},{"name":"Category","spans":[{"start":16,"end":20,"text":"to improved patient survival"}]}]}]},{"target":{"name":"Cause_to_make_progress","spans":[{"start":17,"end":18,"text":"improved"}]},"annotationSets":[{"rank":0,"score":57.22022363111032,"frameElements":[{"name":"Project","spans":[{"start":18,"end":19,"text":"patient"}]}]}]},{"target":{"name":"Rashness","spans":[{"start":18,"end":19,"text":"patient"}]},"annotationSets":[{"rank":0,"score":4.659703380628872,"frameElements":[]}]},{"target":{"name":"Surviving","spans":[{"start":19,"end":20,"text":"survival"}]},"annotationSets":[{"rank":0,"score":14.828081142024843,"frameElements":[{"name":"Dangerous_situation","spans":[{"start":18,"end":19,"text":"patient"}]}]}]}],"tokens":["Therapies","that","effectively","target","and","kill","tumor-initiating","cells","-LRB-","TICs","-RRB-","in","these","cancers","should","translate","to","improved","patient","survival","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":5,"end":6,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":37.42745775502681,"frameElements":[]}]},{"target":{"name":"Assistance","spans":[{"start":6,"end":7,"text":"serve"}]},"annotationSets":[{"rank":0,"score":68.78911864498646,"frameElements":[{"name":"Helper","spans":[{"start":5,"end":6,"text":"tumors"}]},{"name":"Goal","spans":[{"start":7,"end":17,"text":"as excellent models to study tumor biology and characterize TICs"}]}]}]},{"target":{"name":"Usefulness","spans":[{"start":8,"end":9,"text":"excellent"}]},"annotationSets":[{"rank":0,"score":26.057664916502368,"frameElements":[{"name":"Purpose","spans":[{"start":10,"end":17,"text":"to study tumor biology and characterize TICs"}]},{"name":"Entity","spans":[{"start":9,"end":10,"text":"models"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":9,"end":10,"text":"models"}]},"annotationSets":[{"rank":0,"score":24.039432024823284,"frameElements":[{"name":"Use","spans":[{"start":10,"end":17,"text":"to study tumor biology and characterize TICs"}]},{"name":"Vehicle","spans":[{"start":9,"end":10,"text":"models"}]}]}]},{"target":{"name":"Education_teaching","spans":[{"start":11,"end":12,"text":"study"}]},"annotationSets":[{"rank":0,"score":88.72712959645432,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":12,"end":13,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Communicate_categorization","spans":[{"start":15,"end":16,"text":"characterize"}]},"annotationSets":[{"rank":0,"score":28.521413450882317,"frameElements":[{"name":"Speaker","spans":[{"start":0,"end":6,"text":"Patient-derived xenograft -LRB- PDX -RRB- tumors"}]},{"name":"Item","spans":[{"start":16,"end":17,"text":"TICs"}]}]}]}],"tokens":["Patient-derived","xenograft","-LRB-","PDX","-RRB-","tumors","serve","as","excellent","models","to","study","tumor","biology","and","characterize","TICs","."]}
{"frames":[{"target":{"name":"Encoding","spans":[{"start":1,"end":2,"text":"expression"}]},"annotationSets":[{"rank":0,"score":17.86884982538985,"frameElements":[{"name":"Message","spans":[{"start":2,"end":24,"text":"of delta-like 3 -LRB- DLL3 -RRB- was discovered in SCLC and LCNEC PDX tumors and confirmed in primary SCLC and LCNEC tumors"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":4,"end":5,"text":"3"}]},"annotationSets":[{"rank":0,"score":18.594664895710995,"frameElements":[{"name":"Number","spans":[{"start":4,"end":5,"text":"3"}]},{"name":"Entity","spans":[{"start":13,"end":16,"text":"LCNEC PDX tumors"}]}]}]},{"target":{"name":"Becoming_aware","spans":[{"start":9,"end":10,"text":"discovered"}]},"annotationSets":[{"rank":0,"score":81.22845502934548,"frameElements":[{"name":"Phenomenon","spans":[{"start":6,"end":8,"text":"DLL3 -RRB-"}]},{"name":"Ground","spans":[{"start":10,"end":16,"text":"in SCLC and LCNEC PDX tumors"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":15,"end":16,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":36.11456949549798,"frameElements":[]}]},{"target":{"name":"Verification","spans":[{"start":17,"end":18,"text":"confirmed"}]},"annotationSets":[{"rank":0,"score":60.26783566396927,"frameElements":[{"name":"Unconfirmed_content","spans":[{"start":10,"end":16,"text":"in SCLC and LCNEC PDX tumors"}]}]}]},{"target":{"name":"First_rank","spans":[{"start":19,"end":20,"text":"primary"}]},"annotationSets":[{"rank":0,"score":13.13933072529576,"frameElements":[{"name":"Item","spans":[{"start":20,"end":21,"text":"SCLC"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":23,"end":24,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":34.35232136325519,"frameElements":[]}]}],"tokens":["Increased","expression","of","delta-like","3","-LRB-","DLL3","-RRB-","was","discovered","in","SCLC","and","LCNEC","PDX","tumors","and","confirmed","in","primary","SCLC","and","LCNEC","tumors","."]}
{"frames":[{"target":{"name":"Expressing_publicly","spans":[{"start":3,"end":4,"text":"expressed"}]},"annotationSets":[{"rank":0,"score":61.65974329196899,"frameElements":[{"name":"Content","spans":[{"start":0,"end":2,"text":"DLL3 protein"}]}]}]},{"target":{"name":"Part_inner_outer","spans":[{"start":6,"end":7,"text":"surface"}]},"annotationSets":[{"rank":0,"score":13.783569689682823,"frameElements":[{"name":"Part","spans":[{"start":6,"end":7,"text":"surface"}]},{"name":"Whole","spans":[{"start":7,"end":10,"text":"of tumor cells"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":8,"end":9,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":9,"end":10,"text":"cells"}]},"annotationSets":[{"rank":0,"score":20.265593225844544,"frameElements":[{"name":"Building_part","spans":[{"start":9,"end":10,"text":"cells"}]}]}]},{"target":{"name":"Mental_property","spans":[{"start":13,"end":14,"text":"normal"}]},"annotationSets":[{"rank":0,"score":19.1725483288976,"frameElements":[]}]},{"target":{"name":"People_by_age","spans":[{"start":14,"end":15,"text":"adult"}]},"annotationSets":[{"rank":0,"score":27.96381204982695,"frameElements":[{"name":"Person","spans":[{"start":14,"end":15,"text":"adult"}]}]}]}],"tokens":["DLL3","protein","is","expressed","on","the","surface","of","tumor","cells","but","not","in","normal","adult","tissues","."]}
{"frames":[{"target":{"name":"Toxic_substance","spans":[{"start":26,"end":27,"text":"toxin"}]},"annotationSets":[{"rank":0,"score":27.40515715567514,"frameElements":[{"name":"Toxic_substance","spans":[{"start":26,"end":27,"text":"toxin"}]}]}]},{"target":{"name":"Causation","spans":[{"start":28,"end":29,"text":"induced"}]},"annotationSets":[{"rank":0,"score":70.64409099480106,"frameElements":[{"name":"Effect","spans":[{"start":29,"end":38,"text":"durable tumor regression in vivo across multiple PDX models"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":30,"end":31,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":35,"end":36,"text":"multiple"}]},"annotationSets":[{"rank":0,"score":24.623101152885194,"frameElements":[{"name":"Quantity","spans":[{"start":35,"end":36,"text":"multiple"}]},{"name":"Individuals","spans":[{"start":37,"end":38,"text":"models"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":37,"end":38,"text":"models"}]},"annotationSets":[{"rank":0,"score":25.20461819597824,"frameElements":[{"name":"Vehicle","spans":[{"start":37,"end":38,"text":"models"}]}]}]}],"tokens":["A","DLL3-targeted","antibody-drug","conjugate","-LRB-","ADC","-RRB-",",","SC16LD6.5",",","comprised","of","a","humanized","anti-DLL3","monoclonal","antibody","conjugated","to","a","DNA-damaging","pyrrolobenzodiazepine","-LRB-","PBD","-RRB-","dimer","toxin",",","induced","durable","tumor","regression","in","vivo","across","multiple","PDX","models","."]}
{"frames":[{"target":{"name":"Execution","spans":[{"start":3,"end":4,"text":"executed"}]},"annotationSets":[{"rank":0,"score":35.45455368908718,"frameElements":[{"name":"Executed","spans":[{"start":4,"end":29,"text":"with limiting dilutions of cells provided functional evidence confirming that the lack of tumor recurrence after SC16LD6.5 exposure resulted from effective targeting of DLL3-expressing TICs"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":8,"end":9,"text":"cells"}]},"annotationSets":[{"rank":0,"score":22.940803215887037,"frameElements":[{"name":"Building_part","spans":[{"start":8,"end":9,"text":"cells"}]}]}]},{"target":{"name":"Supply","spans":[{"start":9,"end":10,"text":"provided"}]},"annotationSets":[{"rank":0,"score":70.97094475876361,"frameElements":[{"name":"Supplier","spans":[{"start":8,"end":9,"text":"cells"}]},{"name":"Theme","spans":[{"start":10,"end":29,"text":"functional evidence confirming that the lack of tumor recurrence after SC16LD6.5 exposure resulted from effective targeting of DLL3-expressing TICs"}]}]}]},{"target":{"name":"Being_operational","spans":[{"start":10,"end":11,"text":"functional"}]},"annotationSets":[{"rank":0,"score":8.014156762448048,"frameElements":[]}]},{"target":{"name":"Evidence","spans":[{"start":11,"end":12,"text":"evidence"}]},"annotationSets":[{"rank":0,"score":23.561970021088985,"frameElements":[]}]},{"target":{"name":"Statement","spans":[{"start":12,"end":13,"text":"confirming"}]},"annotationSets":[{"rank":0,"score":99.90515839028954,"frameElements":[{"name":"Message","spans":[{"start":13,"end":29,"text":"that the lack of tumor recurrence after SC16LD6.5 exposure resulted from effective targeting of DLL3-expressing TICs"}]},{"name":"Speaker","spans":[{"start":11,"end":12,"text":"evidence"}]}]}]},{"target":{"name":"Possession","spans":[{"start":15,"end":16,"text":"lack"}]},"annotationSets":[{"rank":0,"score":40.4143352912122,"frameElements":[{"name":"Possession","spans":[{"start":16,"end":19,"text":"of tumor recurrence"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":17,"end":18,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Causation","spans":[{"start":22,"end":23,"text":"resulted"}]},"annotationSets":[{"rank":0,"score":70.11201320572481,"frameElements":[{"name":"Cause","spans":[{"start":20,"end":22,"text":"SC16LD6.5 exposure"}]},{"name":"Effect","spans":[{"start":23,"end":29,"text":"from effective targeting of DLL3-expressing TICs"}]}]}]},{"target":{"name":"Usefulness","spans":[{"start":24,"end":25,"text":"effective"}]},"annotationSets":[{"rank":0,"score":20.72013517514753,"frameElements":[{"name":"Entity","spans":[{"start":24,"end":29,"text":"effective targeting of DLL3-expressing TICs"}]}]}]},{"target":{"name":"Purpose","spans":[{"start":25,"end":26,"text":"targeting"}]},"annotationSets":[{"rank":0,"score":31.33474936097106,"frameElements":[]}]}],"tokens":["Serial","transplantation","experiments","executed","with","limiting","dilutions","of","cells","provided","functional","evidence","confirming","that","the","lack","of","tumor","recurrence","after","SC16LD6.5","exposure","resulted","from","effective","targeting","of","DLL3-expressing","TICs","."]}
{"frames":[{"target":{"name":"Encoding","spans":[{"start":6,"end":7,"text":"expression"}]},"annotationSets":[{"rank":0,"score":17.128199466612145,"frameElements":[]}]},{"target":{"name":"Response","spans":[{"start":9,"end":10,"text":"responses"}]},"annotationSets":[{"rank":0,"score":40.939457429052496,"frameElements":[]}]},{"target":{"name":"Statement","spans":[{"start":11,"end":12,"text":"observed"}]},"annotationSets":[{"rank":0,"score":108.76400095861983,"frameElements":[]}]},{"target":{"name":"Vehicle","spans":[{"start":14,"end":15,"text":"models"}]},"annotationSets":[{"rank":0,"score":26.27076526352296,"frameElements":[{"name":"Vehicle","spans":[{"start":14,"end":15,"text":"models"}]}]}]},{"target":{"name":"Activity_start","spans":[{"start":15,"end":16,"text":"initiated"}]},"annotationSets":[{"rank":0,"score":72.7574531356301,"frameElements":[{"name":"Activity","spans":[{"start":16,"end":24,"text":"from patients with both limited and extensive-stage disease"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":19,"end":20,"text":"both"}]},"annotationSets":[{"rank":0,"score":22.140431613805212,"frameElements":[{"name":"Quantity","spans":[{"start":19,"end":20,"text":"both"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":23,"end":24,"text":"disease"}]},"annotationSets":[{"rank":0,"score":31.730135664099585,"frameElements":[{"name":"Ailment","spans":[{"start":23,"end":24,"text":"disease"}]}]}]},{"target":{"name":"Political_locales","spans":[{"start":26,"end":27,"text":"independent"}]},"annotationSets":[{"rank":0,"score":30.22943795305473,"frameElements":[{"name":"Locale","spans":[{"start":26,"end":27,"text":"independent"}]}]}]},{"target":{"name":"Health_response","spans":[{"start":29,"end":30,"text":"sensitivity"}]},"annotationSets":[{"rank":0,"score":19.554162371823445,"frameElements":[{"name":"Protagonist","spans":[{"start":28,"end":29,"text":"their"}]}]}]}],"tokens":["In","vivo","efficacy","correlated","with","DLL3","expression",",","and","responses","were","observed","in","PDX","models","initiated","from","patients","with","both","limited","and","extensive-stage","disease","and","were","independent","of","their","sensitivity","to","standard-of-care","chemotherapy","regimens","."]}
{"frames":[{"target":{"name":"Purpose","spans":[{"start":2,"end":3,"text":"targets"}]},"annotationSets":[{"rank":0,"score":35.9695647665448,"frameElements":[{"name":"Goal","spans":[{"start":1,"end":2,"text":"effectively"}]},{"name":"Agent","spans":[{"start":0,"end":1,"text":"SC16LD6.5"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":12,"end":13,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":36.11456949549798,"frameElements":[]}]},{"target":{"name":"Omen","spans":[{"start":16,"end":17,"text":"promising"}]},"annotationSets":[{"rank":0,"score":29.72335218523301,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":21,"end":22,"text":"treatment"}]},"annotationSets":[{"rank":0,"score":43.5532377894228,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":26,"end":27,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":33.417453802239784,"frameElements":[]}]}],"tokens":["SC16LD6.5","effectively","targets","and","eradicates","DLL3-expressing","TICs","in","SCLC","and","LCNEC","PDX","tumors","and","is","a","promising","first-in-class","ADC","for","the","treatment","of","high-grade","pulmonary","neuroendocrine","tumors","."]}
